Every clinical trial protocol started all participants at 1mg weekly, regardless of their target maintenance dose
Liraglutide is a GLP-1 receptor agonist that mimics the incretin hormone to slow gastric emptying, reduce appetite, and improve glycemic control [1]
This class of medicines has been around since the early 2000s its just only in the more recent time has it been utilised for weight regulation, says Dr Stanford
That eventually manifests as chronic disease
Drinking lots of water can also relieve other Wegovy side effects like bloating, heartburn, and indigestion all of which can boost belching
The mechanism likely involves improved insulin sensitivity directing fuel utilization toward fat oxidation, combined with reduced caloric intake that still provides adequate protein for muscle maintenance in most cases